Here's What Key Metrics Tell Us About Infosys (INFY) Q3 Earnings

Zacks
17 Jan

For the quarter ended December 2024, Infosys (INFY) reported revenue of $4.94 billion, up 5.9% over the same period last year. EPS came in at $0.19, compared to $0.18 in the year-ago quarter.

The reported revenue represents a surprise of +1.16% over the Zacks Consensus Estimate of $4.88 billion. With the consensus EPS estimate being $0.19, the company has not delivered EPS surprise.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Infosys performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Employee Metrics - Software Professionals: 306,528 compared to the 279,486 average estimate based on two analysts.
  • Utilization - Including trainees - Consolidated: 83.4% compared to the 83.2% average estimate based on two analysts.
  • Utilization - Excluding trainees - Consolidated: 86% versus 86% estimated by two analysts on average.
  • Employee Metrics - Sales & Support: 16,851 compared to the 15,607 average estimate based on two analysts.
View all Key Company Metrics for Infosys here>>>

Shares of Infosys have returned +1.1% over the past month versus the Zacks S&P 500 composite's -1.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

American Noble Gas Inc. (INFY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10